{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:46:41Z","timestamp":1790412401987,"version":"4.1.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.3050","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:33:27Z","timestamp":1647603207000},"page":"e223050","source":"Crossref","is-referenced-by-count":65,"title":["Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non\u2013Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013"],"prefix":"10.1001","volume":"5","author":[{"given":"Kelly K.","family":"Bree","sequence":"first","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shan","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hensley","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyati","family":"Lobo","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrui","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Tyler","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Chamie","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"issue":"1","key":"zoi220120r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v71.1","article-title":"Cancer statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10061","key":"zoi220120r2","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer.","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"zoi220120r3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0022-5347(05)67972-4","article-title":"Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome.","volume":"163","author":"Herr","year":"2000","journal-title":"J Urol"},{"issue":"4","key":"zoi220120r4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/bju.v125.4","article-title":"Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG).","volume":"125","author":"Matulay","year":"2020","journal-title":"BJU Int"},{"issue":"4","key":"zoi220120r5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non\u2013muscle invasive bladder cancer: AUA\/SUO guideline.","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"5","key":"zoi220120r6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u20142019 update.","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"issue":"10083","key":"zoi220120r7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/S0140-6736(17)30874-7","article-title":"Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.","volume":"389","author":"Global Burden of Disease Health Financing Collaborator Network","year":"2017","journal-title":"Lancet"},{"key":"zoi220120r8","author":"Matulay","year":"2020"},{"issue":"5","key":"zoi220120r9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life.","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"},{"issue":"49","key":"zoi220120r10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jncimonographs\/lgu018","article-title":"Evaluation of North American Association of Central Cancer Registries\u2019 (NAACCR) data for use in population-based cancer survival studies.","volume":"2014","author":"Weir","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"8","key":"zoi220120r11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2-3","key":"zoi220120r12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.euf.2016.04.008","article-title":"Underutilization of radical cystectomy among patients diagnosed with clinical stage T2 muscle-invasive bladder cancer.","volume":"3","author":"Williams","year":"2017","journal-title":"Eur Urol Focus"},{"issue":"12","key":"zoi220120r14","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data.","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"zoi220120r15","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1200\/JCO.2010.31.1217","article-title":"Cost implications of the rapid adoption of newer technologies for treating prostate cancer.","volume":"29","author":"Nguyen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi220120r17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0022-5347(17)36924-0","article-title":"Treated history of noninvasive grade 1 transitional cell carcinoma.","volume":"148","author":"Prout","year":"1992","journal-title":"J Urol"},{"issue":"6","key":"zoi220120r18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/iju.2006.13.issue-6","article-title":"Recurrence pattern for superficial bladder cancer.","volume":"13","author":"Akagashi","year":"2006","journal-title":"Int J Urol"},{"key":"zoi220120r19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2490-14-5","article-title":"Long term follow-up in patients with initially diagnosed low grade Ta non\u2013muscle invasive bladder tumors: tumor recurrence and worsening progression.","volume":"14","author":"Kobayashi","year":"2014","journal-title":"BMC Urol"},{"issue":"2","key":"zoi220120r20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211721","article-title":"Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non\u2013muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.","volume":"14","author":"Simon","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"zoi220120r22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2016.165","article-title":"Bladder cancer: low adherence to guidelines in non\u2013muscle-invasive disease.","volume":"13","author":"van Rhijn","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"3","key":"zoi220120r23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3800","article-title":"Estimated costs and long-term outcomes of patients with high-risk non\u2013muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin in the Veterans Affairs Health System.","volume":"4","author":"Williams","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"18","key":"zoi220120r24","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1002\/cncr.v125.18","article-title":"The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non\u2013muscle-invasive bladder cancer.","volume":"125","author":"Schroeck","year":"2019","journal-title":"Cancer"},{"key":"zoi220120r25","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.05.009","article-title":"Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy.","author":"Kukreja","year":"2022","journal-title":"Urol Oncol"},{"issue":"6","key":"zoi220120r26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.urology.2005.07.063","article-title":"Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.","volume":"66","author":"Oosterlinck","year":"2005","journal-title":"Urology"},{"key":"zoi220120r27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.urology.2019.04.036","article-title":"Overuse of cystoscopic surveillance among patients with low-risk non\u2013muscle-invasive bladder cancer\u2014a national study of patient, provider, and facility factors.","volume":"131","author":"Han","year":"2019","journal-title":"Urology"},{"issue":"6","key":"zoi220120r28","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"issue":"5","key":"zoi220120r29","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/cncr.v118.5","article-title":"Quality of care in patients with bladder cancer: a case report?","volume":"118","author":"Chamie","year":"2012","journal-title":"Cancer"},{"key":"zoi220120r30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.urology.2019.06.021","article-title":"Compliance with American Urological Association guidelines for nonmuscle invasive bladder cancer remains poor: assessing factors associated with noncompliance and survival in a rural state.","volume":"132","author":"Tobert","year":"2019","journal-title":"Urology"},{"issue":"2","key":"zoi220120r31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1148\/radiol.2502080534","article-title":"What is the current role of CT urography and MR urography in the evaluation of the urinary tract?","volume":"250","author":"Silverman","year":"2009","journal-title":"Radiology"},{"issue":"4","key":"zoi220120r32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/0284186X.2020.1723164","article-title":"Impact of age on bladder cancer management practices: a general population study.","volume":"59","author":"Plouvier","year":"2020","journal-title":"Acta Oncol"},{"issue":"5","key":"zoi220120r33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3961\/jpmph.18.092","article-title":"Demographic and survivorship disparities in non\u2013muscle-invasive bladder cancer in the United States.","volume":"51","author":"Seo","year":"2018","journal-title":"J Prev Med Public Health"},{"issue":"21","key":"zoi220120r34","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1002\/cncr.v127.21","article-title":"The impact of the social construct of race on outcomes among bacille Calmette-Gu\u00e9rin\u2013treated patients with high-risk non\u2013muscle-invasive bladder cancer in an equal-access setting.","volume":"127","author":"Lawler","year":"2021","journal-title":"Cancer"},{"issue":"2","key":"zoi220120r35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010-2020.","volume":"103","author":"Mariotto","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"zoi220120r36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.urology.2009.12.079","article-title":"Regional differences in early stage bladder cancer care and outcomes.","volume":"76","author":"Skolarus","year":"2010","journal-title":"Urology"},{"issue":"1","key":"zoi220120r37","first-page":"15","article-title":"Epidemiology of bladder cancer.","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (Basel)"},{"issue":"17","key":"zoi220120r38","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis.","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"zoi220120r39","doi-asserted-by":"publisher","first-page":"20.e9","DOI":"10.1016\/j.urolonc.2014.08.016","article-title":"Treatment and survival in patients with recurrent high-risk non\u2013muscle-invasive bladder cancer.","volume":"33","author":"Chamie","year":"2015","journal-title":"Urol Oncol"},{"issue":"10","key":"zoi220120r40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamasurg.2018.1680","article-title":"Comparing survival outcomes and costs associated with radical cystectomy and trimodal therapy for older adults with muscle-invasive bladder cancer.","volume":"153","author":"Williams","year":"2018","journal-title":"JAMA Surg"},{"issue":"8","key":"zoi220120r41","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.1629","article-title":"Comparison of costs of radical cystectomy vs trimodal therapy for patients with localized muscle-invasive bladder cancer.","volume":"154","author":"Williams","year":"2019","journal-title":"JAMA Surg"},{"key":"zoi220120r13","unstructured":"US Census Bureau. Zip code census file for SEER-Medicare patients. National Cancer Institute. March 30, 2015. Accessed August 1, 2021. https:\/\/healthcaredelivery.cancer.gov\/seer-cahps\/medicare\/zipcode.census.file.pdf"},{"key":"zoi220120r16","unstructured":"US Bureau of Labor Statistics. Consumer Price Index (CPI) databases: all urban consumers. US Bureau of Labor Statistics; 2020. Accessed August 1, 2021. https:\/\/www.bls.gov\/cpi\/data.htm#"},{"key":"zoi220120r21","unstructured":"Babjuk? M, Burger? M, Comp\u00e9rat? E, . Non\u2013muscle-invasive bladder cancer. European Association of Urology; 2021. Accessed September 1, 2021. https:\/\/uroweb.org\/guideline\/non-muscle-invasive-bladder-cancer\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2790255\/bree_2022_oi_220120_1647021122.74839.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:33:37Z","timestamp":1647603217000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2790255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.3050","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}